Genetic aberrations of PTEN are not frequent in NSCLC; by contrast, in about 35% of early stage NSCLC samples the lack of PTEN protein expression observed was reported to correlate with hypermethylation at the promoter gene region. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.